Prenatal screening for fetal defects
has become a standard part of pregnancy medical care in the past couple of decades. Tests are typically conducted during the first half of pregnancy in order to detect a wide range of genetic and other disorders, and to give women the option of obtaining abortions if in case any defects are diagnosed. While some people believe this as a breakthrough in the prevention or eradications of diseases, it has significantly contributed to the improvement of society as a whole.
Due to the availability of many kinds of tests, parents are currently selecting the safer ones and also the technological developments have generally made the process of testing safe. These tests are also very effective and accurate, with several disorders being detected using single test, thus reducing the need for multiple visits and tests. The global market for Prenatal testing and newborn screening
was estimated to be $XX billion in 2014. The global market for Prenatal testing and new born screening is estimated to grow at a CAGR of XX% and is forecast to reach $XX billion by 2020. Prenatal testing market is forecast to have the highest growth of XX% during the forecast period 2015-2020. Health Care is the major end-user of prenatal testing and newborn screening. North America and Asia alone are estimated to occupy a share of more than XX% during 2015-2021.
North America is the leading market for prenatal testing and newborn screening with U.S leading the charge. Asia region is forecast to have highest growth in the next few years due to growing adoption of prenatal testing and newborn screening in industrial applications. Asia Prenatal testing and newborn screening market accounts to xx% of the global market. Asia is the fastest growing market followed by Americas.